The incidence of respiratory symptoms and their associations with serum cotinine levels as a marker of tobacco smoking in 25-45-year-old Novosibirsk dwellers


Cite item

Full Text

Abstract

Aim. To study the incidence of respiratory symptoms and to reveal their associations with serum cotinine levels (SCL) in 25—45-year-old Novosibirsk dwellers. Subjects and methods. The WHO respiratory symptom questionnaire and the ECRHS screening questionnaire were used for a population-based survey conducted in Novosibirsk to identify respiratory symptoms; 545 people replied to the questions available in the questionnaires. SCL was determined by enzyme immunoassay on a random subsample of 182 examinees. Results. The incidence of respiratory symptoms was determined among the 25—45-year-old Novosibirsk dwellers: cough (27.7%), more than 3-month cough per year (22%), sputum discharge (25%), forced respiration/wheezing in the past year (22.6%), suffocation fits in the past year (5.3%), and cough/forced respiration/stertor bouts by breathing cold air (14.9%) or contacting animals, plants, or chemical agents (16.5%). There was a significant positive correlation between SCL and the presence of cough, more than 3-month cough per year, sputum discharge, forced respiration/wheezing in the past year (compared to the examinees who did not report these symptoms). The median SCL proved to be significantly higher in the people who complained of cough, more than 3-month cough per year, sputum discharge, and forced respiration/wheezing in the past year (compared to the examinees who did not report these symptoms). The people who had a SCL of more than 3 ng/ml were ascertained to be at higher risk of cough, more than 3-month cough per year, sputum discharge, and forced respiration/wheezing in the past year than those who had a SCL of less than 3 ng/ml. Conclusion. The incidence of respiratory symptoms was determined among the 25-45-year-old Novosibirsk dwellers; SCL was found to be associated with the symptoms characteristic of bronchial obstructive diseases; the expediency of using the SCL threshold of 3 ng/ml as a marker of tobacco smoking was confirmed.

References

  1. Биличенко Т.Н., Чучалин А.Г., Сон И.М. Основные итоги развития специализированной медицинской помощи больным пульмонологического профиля на территории Российской Федерации за период 2004—2010 гг. Пульмонология. 2012;3:5-16.
  2. Dr. Ala Alwan. Global status report on noncommunicable diseases 2010. Geneva: World Health Organization; 2011:165.
  3. Vestbo J, Hurd SS, Agustí AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, Stockley RA, Sin DD, Rodriguez-Roisin R. Global Strategy For The Diagnosis, Management, And Prevention Of Chronic Obstructive Pulmonary Disease. Am J RespirCrit Care Med. 2013;187(4):347-365. doi: 10.1164/rccm.201204-0596pp.
  4. Benowitz N. Cotinine as a Biomarker of Environmental Tobacco Smoke Exposure. Epidemiol Rev. 1996;18(2):188-204. doi: 10.1093/oxfordjournals.epirev.a017925.
  5. Benowitz N, Bernert J, Caraballo R, Holiday D, Wang J. Optimal Serum Cotinine Levels for Distinguishing Cigarette Smokers and Nonsmokers Within Different Racial/Ethnic Groups in the United States Between 1999 and 2004. Am J Epidemiol. 2008;169(2): 236-248. doi: 10.1093/aje/kwn301.
  6. Чернушенко Т.И. Эпидемиология табакокурения и других факторов риска хронической обструктивной болезни лёгких в промышленном городе Кузбасса: Автореф. дис. ... канд. мед. наук. Томск; 2014. Доступно по: http://dlib.rsl.ru/01005546981. Ссылка активна на 12.10.15.
  7. Perlman F, Bobak M, Gilmore A, McKee M. Trends in the prevalence of smoking in Russia during the transition to a market economy. Tobacco Control. 2007;16(5):299-305. doi: 10.1136/tc.2006.019455.
  8. Ковалькова Н.А., Логвиненко Н.И., Малютина С.К. и др. Ассоциации факторов риска ишемической болезни сердца и бронхообструктивного синдрома в городской сибирской популяции. Атеросклероз. 2014;1(10):32-38.
  9. Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, FitzGerald M, Gibson P, Ohta K, O’Byrne P, Pedersen SE, Pizzichini E, Sullivan SD, Wenzel SE, Zar HJ. Global Strategy For Asthma Management And Prevention: GINA Executive Summary. Eur Respiratory J. 2008;31(1):143-178. doi: 10.1183/09031936.00138707.
  10. Ханин А.Л., Чернушенко Т.И., Морозова Г.В., Савельева И.А. Распространенность респираторных симптомов и возможности выявления хронической обструктивной болезни легких в шахтерском городе Кузбасса. Пульмонология. 2012;3:59-62.
  11. Можина Л.Н., Манжилеева Т.В., Сидорова Л.Д. Заболеваемость бронхиальной астмой в г. Новосибирске по данным программы уточненной регистрации. Сибирский консилиум. 2007;1(56):55-61.
  12. To T, Stanojevic S, Moores G, Gershon A, Bateman E, Cruz A, Boulet L. Global asthma prevalence in adults: findings from the cross-sectional world health survey. BMCPublic Health. 2012; 12(1):204. doi: 10.1186/1471-2458-12-204.
  13. Денисова Д.В., Ковалькова Н.А., Каштанова Е.В., Каштанова Е.В., Полонская Я.В., Щербакова Л.В. Курение и его ассоциации с социально-экономическими и кардиометаболическими факторами риска в популяции 25—45 лет г. Новосибирска. Проблема женского курения (2013—2014). Атеросклероз. 2014;3(10):61-68.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2016 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 

Address of the Editorial Office:

  • Novij Zykovskij proezd, 3, 40, Moscow, 125167

Correspondence address:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Managing Editor:

  • Tel.: +7 (926) 905-41-26
  • E-mail: e.gorbacheva@ter-arkhiv.ru

 

 © 2018-2021 "Consilium Medicum" Publishing house


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies